HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Qi Huang Selected Research

Blood Glucose (Blood Sugar)

4/2023How does obesity affect mortality through blood pressure and blood glucose in Chinese and US citizens? Insights from a causal mediation analysis of two large cohorts.
8/2021Isoeucommin A attenuates kidney injury in diabetic nephropathy through the Nrf2/HO-1 pathway.
4/2019[Electroacupuncture reduces obesity by improving metabolism and up-regulating expression of hypothalamic Sirtuin 1 and proopiomelanocortin in obese rats].
10/2018[Risk factors analysis of acute respiratory distress syndrome in intensive care unit traumatic patients].
6/2018[Progress of therapeutic strategies for glucose metabolic disorders in sepsis].
1/2018Atherogenic Index in Type 2 Diabetes and Its Relationship with Chronic Microvascular Complications.
11/2014NR4A1 is associated with chronic low-grade inflammation in patients with type 2 diabetes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Qi Huang Research Topics

Disease

123Neoplasms (Cancer)
04/2024 - 03/2005
38Inflammation (Inflammations)
04/2024 - 12/2010
29Infections
04/2024 - 12/2004
19Cognitive Dysfunction
05/2024 - 01/2016
18Alzheimer Disease (Alzheimer's Disease)
05/2024 - 01/2017
18Lung Neoplasms (Lung Cancer)
04/2024 - 06/2004
18Obesity
01/2024 - 01/2011
16Colorectal Neoplasms (Colorectal Cancer)
08/2023 - 06/2005
14Neoplasm Metastasis (Metastasis)
01/2024 - 03/2012
13Carcinogenesis
11/2022 - 10/2013
12Body Weight (Weight, Body)
11/2023 - 12/2008
12Insulin Resistance
11/2023 - 12/2008
11Fibrosis (Cirrhosis)
01/2024 - 09/2015
11Type 2 Diabetes Mellitus (MODY)
11/2023 - 05/2004
11Adenocarcinoma of Lung
10/2023 - 03/2005
10Hepatocellular Carcinoma (Hepatoma)
11/2023 - 08/2014
10Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2023 - 01/2005
8COVID-19
04/2024 - 01/2020
8Lymphatic Metastasis
01/2024 - 01/2005
8Glioma (Gliomas)
12/2023 - 01/2018
8Chronic Hepatitis B
01/2023 - 10/2016
8Stomach Neoplasms (Stomach Cancer)
01/2022 - 06/2005
7Reperfusion Injury
09/2023 - 05/2007
7Breast Neoplasms (Breast Cancer)
12/2022 - 11/2017
6Nasopharyngeal Carcinoma
01/2024 - 05/2009
6Prostatic Neoplasms (Prostate Cancer)
12/2023 - 01/2017
6Diabetic Nephropathies (Diabetic Nephropathy)
07/2023 - 01/2014
6Seizures (Absence Seizure)
01/2023 - 10/2012
6Pain (Aches)
01/2021 - 03/2017
5Epilepsy (Aura)
01/2024 - 01/2015
5Asthma (Bronchial Asthma)
12/2023 - 07/2019
5Necrosis
12/2023 - 05/2007
5Ulcerative Colitis
12/2023 - 12/2010
5Neuroinflammatory Diseases
08/2023 - 02/2019
5Disease Progression
06/2023 - 06/2019
5Hemorrhage
01/2023 - 10/2010
5Hyperglycemia
12/2022 - 05/2017
5Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2022 - 03/2005
5Sepsis (Septicemia)
01/2021 - 01/2018
5Myocardial Infarction
01/2021 - 06/2009
5Tuberculosis (Tuberculoses)
08/2020 - 10/2014
4Wounds and Injuries (Trauma)
06/2023 - 10/2018
4Hypoxia (Hypoxemia)
05/2023 - 01/2022
4Ischemic Stroke
11/2022 - 01/2018
4Uterine Hemorrhage (Uterine Bleeding)
08/2022 - 11/2019
4Hearing Loss (Hearing Impairment)
11/2020 - 01/2012
4Iron Overload
01/2020 - 01/2016

Drug/Important Bio-Agent (IBA)

44Proteins (Proteins, Gene)FDA Link
11/2023 - 12/2004
36Biomarkers (Surrogate Marker)IBA
03/2024 - 06/2005
30Glucose (Dextrose)FDA LinkGeneric
03/2024 - 05/2004
23Messenger RNA (mRNA)IBA
01/2022 - 09/2009
18CytokinesIBA
01/2024 - 12/2008
14RNA (Ribonucleic Acid)IBA
01/2024 - 10/2016
14MicroRNAs (MicroRNA)IBA
01/2023 - 01/2015
12Circular RNAIBA
12/2023 - 01/2018
11Therapeutic UsesIBA
02/2024 - 09/2017
11LipidsIBA
12/2023 - 05/2014
11Interleukin-6 (Interleukin 6)IBA
11/2023 - 11/2016
10Amyloid (Amyloid Fibrils)IBA
05/2024 - 01/2022
10Interleukin-17 (Interleukin 17)IBA
08/2022 - 01/2013
9salicylhydroxamic acid (SHAM)IBA
06/2023 - 01/2015
8DNA (Deoxyribonucleic Acid)IBA
01/2023 - 03/2014
7Antiviral Agents (Antivirals)IBA
01/2024 - 01/2020
7Blood Glucose (Blood Sugar)IBA
04/2023 - 11/2014
7Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
04/2023 - 01/2018
7Long Noncoding RNAIBA
11/2022 - 01/2018
7Transcription Factors (Transcription Factor)IBA
01/2022 - 01/2018
6Sirtuin 1IBA
11/2023 - 05/2017
6Insulin (Novolin)FDA Link
01/2022 - 07/2005
5Amyloid beta-PeptidesIBA
04/2024 - 01/2021
5Immune Checkpoint InhibitorsIBA
04/2024 - 01/2023
5Glucagon-Like Peptide 1 (GLP 1)IBA
11/2023 - 05/2004
5AntibodiesIBA
10/2023 - 01/2018
5Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
06/2023 - 10/2013
5Oxygen (Dioxygen)IBA
01/2023 - 10/2018
5VaccinesIBA
10/2022 - 08/2012
5Phosphotransferases (Kinase)IBA
03/2022 - 08/2012
5Hormones (Hormone)IBA
01/2022 - 07/2005
5N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
01/2022 - 12/2016
5Indicators and Reagents (Reagents)IBA
01/2022 - 01/2005
5AlbuminsIBA
08/2021 - 01/2017
5AntigensIBA
01/2020 - 01/2017
4Immunoglobulin G (IgG)IBA
04/2024 - 01/2022
4Cadherins (E-Cadherin)IBA
01/2024 - 01/2016
4Peroxisome Proliferator-Activated Receptors (PPAR)IBA
11/2023 - 01/2018
4Hemostatics (Antihemorrhagics)IBA
01/2023 - 11/2019
4AntioxidantsIBA
01/2023 - 08/2016
4CreatinineIBA
08/2021 - 01/2018
4EnzymesIBA
03/2021 - 08/2018
4Small Interfering RNA (siRNA)IBA
12/2020 - 10/2014
4CholesterolIBA
12/2020 - 09/2006

Therapy/Procedure

42Therapeutics
04/2024 - 09/2004
13Immunotherapy
03/2024 - 01/2021
13Drug Therapy (Chemotherapy)
12/2023 - 08/2008
8Length of Stay
01/2023 - 10/2010
7Electroacupuncture
11/2023 - 04/2019
7Aftercare (After-Treatment)
06/2022 - 03/2007
6Radiotherapy
10/2023 - 08/2008
5Cochlear Implantation
11/2020 - 03/2010
4Chinese Traditional Medicine (Traditional Chinese Medicine)
11/2023 - 03/2007